Benzaldehyde

Benzaldehyde

SCHEMBL432383

COC(C)OC.O=Cc1ccccc1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.61
CYP2A6 P11509 3/20 0.61
ALDH1A3 P47895 1/20 0.45
TYR P14679 1/20 0.45
KMT2A Q03164 2/20 0.41
TTR P02766 1/20 0.40
PPARG P37231 1/20 0.40
TRPA1 O75762 2/20 0.38
TSHR P16473 2/20 0.38
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
LMNA P02545 1/20 0.37
ALOX5 P09917 1/20 0.37
MAPK1 P28482 1/20 0.37
DRD1 P21728 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2522159 0.88 ALDH1A1 (0.46) ALDH1A1CYP2A6ALDH1A3TYRTTR
Isophthalic Dicarboxaldehyde SCHEMBL3536987 0.85 ALDH1A1 (0.47) ALDH1A1CYP2A6ALDH1A3TYRTTR
Benzaldehyde SCHEMBL28430047 0.84 ALDH1A1 (0.78) ALDH1A1CYP2A6ALDH1A3TYRKMT2A
SCHEMBL10804430 0.81 CYP2A6 (0.67) ALDH1A1CYP2A6ALDH1A3TYRTSHR
Cinnamic Aldehyde SCHEMBL10420989 0.80 TRPA1 (0.67) ALDH1A1TRPA1MAOBLMNAALOX5
Benzaldehyde SCHEMBL9700513 0.79 ALDH1A1 (0.70) ALDH1A1CYP2A6ALDH1A3TYRKMT2A
Benzaldehyde SCHEMBL27524489 0.79 ALDH1A1 (0.70) ALDH1A1CYP2A6ALDH1A3TYRKMT2A
Benzaldehyde SCHEMBL28089311 0.79 ALDH1A1 (0.70) ALDH1A1CYP2A6ALDH1A3TYRKMT2A
Benzaldehyde SCHEMBL28226038 0.79 ALDH1A1 (0.70) ALDH1A1CYP2A6ALDH1A3TYRKMT2A
Benzaldehyde SCHEMBL4359974 0.79 ALDH1A1 (0.70) ALDH1A1CYP2A6ALDH1A3TYRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 676 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250170237-A1 MURAMYL DIPEPTIDES AND PROCESS FOR PREPARATION THEREOF UNIVERSITEIT GENT (BE) 2025-05-29 US claimed
CN-119549163-A Preparation method and application of Cu-based catalyst for acetalation reaction 西北工业大学 2025-03-04 CN claimed
CN-119114033-A Low-protein-adsorptivity blood perfusion adsorbent, preparation method thereof and blood perfusion device 泉州师范学院 2024-12-13 CN claimed
EP-2844065-B1 LURE COMPOSITION ATTRATEC GMBH (DE) 2021-01-06 EP claimed
WO-2017207542-A1 METHOD FOR PREPARATION OF MANNOSIDE DERIVATIVES ÅBO AKADEMI UNIVERSITY (FI) 2017-12-07 WO claimed
EP-3252056-A1 METHOD FOR PREPARATION OF MANNOSIDE DERIVATIVES Åbo Akademi University (FI) 2017-12-06 EP claimed
EP-2130816-B1 Triarylmethanes and processes for making the same XEROX CORP (US) 2017-08-23 EP claimed
EP-2581359-B1 REAGENT FOR TESTING PURIFICATION CAPACITY OF RADIOACTIVE GAS IN A NUCLEAR POWER PLANT, PREPARATION METHOD THEREOF AND IODIDE FILTER TESTING EQUIPMENT USING THIS REAGENT CHINA GENERAL NUCLEAR POWER (CN) 2016-03-30 EP claimed
US-8569490-B2 Intermediate and process for preparing entecavir using same HANMI SCIENCE CO., LTD (KR) 2013-10-29 US claimed
EP-2382217-B1 NOVEL INTERMEDIATE AND PROCESS FOR PREPARING ENTECAVIR USING SAME HANMI SCIENCE CO LTD (KR) 2013-10-23 EP claimed
EP-0998351-B1 USE OF TRIS (TRIFLUORO METHYLSULFONYL) METHANE, IN ADDITION TO ALKALINE METAL SALTS AND ALKALINE-EARTH METAL SALTS THEREOF AS CATALYSTS DURING C-C BONDING SYNTHESES AND THE NOVEL Mg SALT OF TRIS (TRIFLUORO METHYLSULFONYL) METHANE MERCK PATENT GMBH (DE) 2001-05-30 EP claimed
EP-0788504-A1 STEREODIRECTED PROCESS FOR SYNTHESIS OF ALPHA-N-ACETYLGALACTOSAMINIDES BIOMIRA, INC. (CA) 1997-08-13 EP claimed
US-5527891-A REACTING N-ACETYLGALACTOSAMINE WITH DIALKYL ACETAL OF ALDEHYDE OR KETONE, PROTECTING 3-HYDROXY GROUP, INTRODUCING ANOMERIC GROUP TO FORM GLYCOSYL DONOR, REACTING WITH ALCOHOL BIOMIRA, INC. (CA) 1996-06-18 US claimed
WO-1995024701-A1 STEREODIRECTED PROCESS FOR SYNTHESIS OF α-N-ACETYLGALACTOSAMINIDES BIOMIRA, INC. (CA) 1995-09-14 WO claimed
EP-0381114-B1 Exo-3',4'-0-benzylidene-3\"-demethylchartreusin and its salts ISHIHARA SANGYO KAISHA (JP) 1994-09-28 EP claimed
EP-0252525-B1 Alpha-amylase assay using modified oligosaccharide and process for producing said modified oligosaccharide WAKO PURE CHEM IND LTD (JP) 1993-11-10 EP claimed
US-5192666-A α-amylase assay using modified oligosaccharide and process for producing said modified oligosaccharide WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 1993-03-09 US claimed
EP-0411750-A2 Organic stabilizers for isothiazolones ROHM AND HAAS COMPANY (US) 1991-02-06 EP claimed
EP-0381114-A2 Exo-3',4'-0-benzylidene-3\"-demethylchartreusin and its salts ISHIHARA SANGYO KAISHA, LTD. (JP) 1990-08-08 EP claimed
US-4097661-A ORGANO-SODIUM CONTAINING ALFIN CATALYST, HYDROCARBON SOLVENT, MOLECULAR WEIGHT REGULATOR JAPAN SYNTHETIC RUBBER CO., LTD. (JA) 1978-06-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250170237-A1 MURAMYL DIPEPTIDES AND PROCESS FOR PREPARATION THEREOF NOD2, NOD1, TLR9 ALDH1A1 4872/4885CYP2A6 4729/4885ALDH1A3 4862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.